Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the cost of lost productivity in the workplace due to allergic rhinitis compared to other selected medical conditions from an employer perspective. SETTING AND PARTICIPANTS: A total of 8267 US employees at 47 employer locations who volunteered to participate in health/wellness screenings. MEASUREMENTS: The Work Productivity Short Inventory was used to assess the impact of a predefined group of health conditions on workplace productivity for the previous 12 months. Both absenteeism and presenteeism (lost productivity while at work) were recorded. Costs were calculated using a standard hourly wage. RESULTS: Allergic rhinitis was the most prevalent of the selected conditions; 55% of employees reported experiencing allergic rhinitis symptoms for an average of 52.5 days, were absent 3.6 days per year due to the condition, and were unproductive 2.3 h per workday when experiencing symptoms. The mean total productivity (absenteeism + presenteeism) losses per employee per year were 593 US dollars for allergic rhinitis, 518 US dollars for high stress, 277 US dollars for migraine, 273 US dollars for depression, 269 US dollars for arthritis/rheumatism, 248 US dollars for anxiety disorder, 181 US dollars for respiratory infections, 105 US dollars for hypertension or high blood pressure, 95 US dollars for diabetes, 85 US dollars for asthma, and 40 US dollars for coronary heart disease. The mean total productivity loss per employee per year due to caregiving was 102 US dollars for pediatric respiratory infections, 85 US dollars for pediatric allergies, 49 US dollars for Alzheimer's disease, and 42 US dollars for otitis media/earache. CONCLUSIONS: Allergies are major contributors to the total cost of health-related absenteeism and presenteeism. Payers and employers need to consider this when determining health benefits for employees.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a survey of over 8000 U.S. employees at 47 employer locations, 55% reported AR symptoms for an average of 52.5 days per year. They reported missing 3.6 days of work per year because of AR and reported being unproductive 2.3 hours per workday when symptomatic. The mean total productivity losses (absenteeism and presenteeism) for AR were calculated at $593 per employee per year.769”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [769]
Citations
Cites
The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
Current estimates from the National Health Interview Survey.
Ss, J. (1981) · PubMed · Cited by 1,866
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242
The Work Limitations Questionnaire
Lerner, D., Amick, B. C., Rogers, W. H., Malspeis, S., Bungay, K., & Cynn, D. (2001) · Medical Care · doi:10.1097/00005650-200101000-00009 · Cited by 971
Stanford Presenteeism Scale: Health Status and Employee Productivity
Koopman, C., Pelletier, K. R., Murray, J. F., Sharda, C. E., Berger, M. L., Turpin, R. S., Hackleman, P., Gibson, P., Holmes, D. M., & Bendel, T. (2002) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200201000-00004 · Cited by 821
Dykewicz, M. S., Fineman, S., Skoner, D. P., Nicklas, R., Lee, R., Blessing-Moore, J., Li, J. T., Bernstein, I. L., Berger, W., Spector, S., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63155-9 · Cited by 652
The effects of chronic medical conditions on work loss and work cutback
Kessler, R. C., Greenberg, P. E., Mickelson, K. D., Meneades, L. M., & Wang, P. S. (2001) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200103000-00009 · Cited by 468
Kessler, R. C., Barber, C., Birnbaum, H. G., Frank, R. G., Greenberg, P. E., Rose, R. M., Simon, G. E., & Wang, P. (1999) · Health Affairs · doi:10.1377/hlthaff.18.5.163 · Cited by 388
Labor and Health Status in Economic Evaluation of Health Care: The Health and Labor Questionnaire
Van Roijen, L., Essink-bot, M.-L., Koopmanschap, M. A., Bonsel, G., & Rutten, F. F. H. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009764 · Cited by 303
Corren, J., Adinoff, A. D., Buchmeier, A. D., & Irvin, C. G. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90079-h · Cited by 290
Research works printed but not linked: 5
- Adams PF, 1995, Vital Health Stat, 193, 1
- Collins JG, 1989, Adv Data, 168, 1
- Murray JJ, 2002, Allergy Asthma Proc, 23, 391
- Ross RN, 1996, Am J Managed Care, 2, 285
- Endicott J, 1997, Psychopharmacol Bull, 33, 13
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
“The mean total productivity (absenteeism and presenteeism) losses per employee per year were US$ 593 for allergic rhinitis which was the first most costly disease of the study (562).”
BackgroundInfluentialEconomic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,163
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
“• Moreover, work disability is common among adults with severe asthma (559, 560) and rhinitis productivity (84, 562).”
BackgroundClinical Practice Guideline: Allergic Rhinitis
Seidman, M. D., Gurgel, R. K., Lin, S. Y., Schwartz, S. R., Baroody, F. M., Bonner, J. R., Dawson, D. E., Dykewicz, M. S., Hackell, J. M., Han, J. K., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599814561600 · Cited by 671
Employee Health and Presenteeism: A Systematic Review
Schultz, A. B., & Edington, D. W. (2007) · Journal of Occupational Rehabilitation · doi:10.1007/s10926-007-9096-x · Cited by 567
“Quantity of studies: Three peer-reviewed studies were found on the topic of allergies and presenteeism [21, 64, 65].”
BackgroundInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
What Does Research Tell Us About Depression, Job Performance, and Work Productivity?
Lerner, D., & Henke, R. M. (2008) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e31816bae50 · Cited by 509
“Another workplace study estimated the annual cost of depression at $273 per employee in the workforce, but these figures were not directly comparable because they include costs associated with both reduced absenteeism and presenteeism and used a different method of assigning cost.(57) In clinical studies testing the e…”
MethodBurden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy
Dierick, B. J. H., van der Molen, T., Flokstra-de Blok, B. M. J., Muraro, A., Postma, M. J., Kocks, J. W. H., & van Boven, J. F. M. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1819793 · Cited by 377
“518 USD (compared to 95 USD for diabetes, 85 USD for asthma, and 40 USD for coronary heart disease) [66].”
BackgroundResultDall, T. M., Yang, W., Halder, P., Pang, B., Massoudi, M., Wintfeld, N., Semilla, A. P., Franz, J., & Hogan, P. F. (2014) · Diabetes Care · doi:10.2337/dc14-1036 · Cited by 382
Pfaar, O., Bachert, C., Bufe, A., Buhl, R., Ebner, C., Eng, P., Friedrichs, F., Fuchs, T., Hamelmann, E., Hartwig-Bade, D., et al. (2014) · Allergo Journal International · doi:10.1007/s40629-014-0032-2 · Cited by 351
“e healthcare system is burdened not only by the costs caused directly by disease, but also by the indirect costs that are o en challenging to measure [32].”
BackgroundPresenteeism and absenteeism: Differentiated understanding of related phenomena.
Gosselin, E., Lemyre, L., & Corneil, W. (2013) · Journal of Occupational Health Psychology · doi:10.1037/a0030932 · Cited by 273
The economic impact of allergic rhinitis and current guidelines for treatment
Meltzer, E. O., & Bukstein, D. A. (2011) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.10.014 · Cited by 268
Impact of Rhinitis on Work Productivity: A Systematic Review
Vandenplas, O., Vinnikov, D., Blanc, P. D., Agache, I., Bachert, C., Bewick, M., Cardell, L.-O., Cullinan, P., Demoly, P., Descatha, A., et al. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.09.002 · Cited by 243
“25 11 Outcomes 1 Seven surveys collected data on the impact of AR on work productivity using validated 2 instruments (Table 1): the WPAI instrument either in its specific version for allergic diseases 3 (WPAI-AS) (17, 19, 30, 43) or in its generic version (25), the Stanford Presenteeism Scale 4 (SPS) (44), and the Wor…”
BackgroundInfluentialBernstein, D. I., Schwartz, G., & Bernstein, J. A. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.12.004 · Cited by 240
Kakli, H. A., & Riley, T. D. (2016) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2016.04.009 · Cited by 200
Zielen, S., Devillier, P., Heinrich, J., Richter, H., & Wahn, U. (2018) · Allergy · doi:10.1111/all.13213 · Cited by 184
“Moderate-to-severe symptoms of AR have a negative impact on quality of life, workplace productivity, and school performance.(7-9) AR is also associated with an increased risk or worsening of allergic asthma.”
BackgroundAllergic Rhinitis: an Overview
Varshney, J., & Varshney, H. (2015) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-015-0828-5 · Cited by 173
Kigozi, J., Jowett, S., Lewis, M., Barton, P., & Coast, J. (2017) · Value in Health · doi:10.1016/j.jval.2016.12.006 · Cited by 162
“[70] United States Allergic rhinitis COI Lerner et al.”
InfluentialMACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
Bousquet, J., Schünemann, H. J., Hellings, P. W., Arnavielhe, S., Bachert, C., Bedbrook, A., Bergmann, K.-C., Bosnic-Anticevich, S., Brozek, J., Calderon, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.025 · Cited by 168
Bousquet, J., Hellings, P. W., Agache, I., Bedbrook, A., Bachert, C., Bergmann, K. C., Bewick, M., Bindslev-Jensen, C., Bosnic-Anticevitch, S., Bucca, C., et al. (2016) · Clinical and Translational Allergy · doi:10.1186/s13601-016-0137-4 · Cited by 160
Burden of allergic respiratory disease: a systematic review
Linneberg, A., Dam Petersen, K., Hahn-Pedersen, J., Hammerby, E., Serup-Hansen, N., & Boxall, N. (2016) · Clinical and Molecular Allergy · doi:10.1186/s12948-016-0049-9 · Cited by 151
“In 2006, the cost of lost productivity in the workplace due to AR was $593 per employee per year, and exceeded that of stress ($518), migraine ($277), depression ($273), and arthritis/rheumatism ($269) [36].”
BackgroundMarple, B. F., Fornadley, J. A., Patel, A. A., Fineman, S. M., Fromer, L., Krouse, J. H., Lanier, B. Q., Penna, P., & American Academy of Otolaryngic Allergy Working Group on Allergic Rhinitis (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2007.02.031 · Cited by 147
“3 hours per day while they were symptomatic.(27) The employees who cared for a child with allergic rhinitis were absent from work for 3.”
BackgroundRole of mechanical ventilation in the airborne transmission of infectious agents in buildings
Luongo, J. C., Fennelly, K. P., Keen, J. A., Zhai, Z. J., Jones, B. W., & Miller, S. L. (2016) · Indoor Air · doi:10.1111/ina.12267 · Cited by 135
“The estimated mean total productivity losses from absenteeism and presenteeism (lost productivity while at work) was $181 per employee per year for respiratory infections (Lamb et al.”
BackgroundBrooks, A., Hagen, S. E., Sathyanarayanan, S., Schultz, A. B., & Edington, D. W. (2010) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e3181f475cc · Cited by 136
Zhang, Y., Bielory, L., Mi, Z., Cai, T., Robock, A., & Georgopoulos, P. (2015) · Global Change Biology · doi:10.1111/gcb.12755 · Cited by 130
“It acts synergistically with common air pollutants, such as ozone and particulate matter, to exacer- bate allergic airway disease (Cakmak et al., 2012), resulting in related high medical costs (Lamb et al., 2006).”
Dog and Cat Allergies: Current State of Diagnostic Approaches and Challenges
Chan, S. K., & Leung, D. Y. M. (2018) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2018.10.2.97 · Cited by 124
“It was the most costly disease in the United States with an estimated at $593 USD per employee per year in lost productivity (absenteeism+unproductive) without accounting for the cost of asthma excerbations.(3) Cats and dogs are the most prevalent household pets.”
BackgroundAllergy immunotherapy: the future of allergy treatment
Larsen, J. N., Broge, L., & Jacobi, H. H. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.010 · Cited by 144
Guideline on allergen immunotherapy in IgE-mediated allergic diseases
Pfaar, O., Ankermann, T., Augustin, M., Bubel, P., Böing, S., Brehler, R., Eng, P. A., Fischer, P. J., Gerstlauer, M., Hamelmann, E. H., et al. (2022) · Allergologie select · doi:10.5414/alx02331e · Cited by 136
Benninger, M. S., Farrar, J. R., Blaiss, M. S., Chipps, B. E., Ferguson, B. J., Krouse, J. H., Marple, B. F., Storms, W. W., & Kaliner, M. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2009.11.020 · Cited by 132
The Economic and Social Burden of Low Back Pain in Spain
García, M. A., & Sarría‐Santamera, A. (2020) · Spine · doi:10.1097/brs.0000000000003476 · Cited by 129
House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies
Calderón, M. A., Kleine‐Tebbe, J., Linneberg, A. R., Frederic de, B. L. A. Y., de Rojas, D. H. F., Virchow, J. C., Jr., & Demoly, P. M. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.06.019 · Cited by 137
Bjermer, L. H., Westman, M., Holmström, M., & Wickman, M. C. (2019) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0314-1 · Cited by 131
Burton, W. N., Landy, S. H., Downs, K. E., & Runken, M. C. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60562-4 · Cited by 111
Rinite alérgica: indicadores de qualidade de vida
Camelo‐Nunes, I. C., & Solé, D. (2010) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132010000100017 · Cited by 157
Caballer, B. D. L. H., Rodríguez, M., Fraj, J., Cerecedo, I., Antolín-Amérigo, D., & Colas, C. (2012) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2012.26.3799 · Cited by 106
The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
Price, D., Scadding, G., Ryan, D., Bachert, C., Canonica, G. W., Mullol, J., Klimek, L., Pitman, R., Acaster, S., Murray, R., et al. (2015) · Clinical and Translational Allergy · doi:10.1186/s13601-015-0083-6 · Cited by 105
“productivity loss or under-performance at work and school) [18–21].”
BackgroundFunctional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction
Schumann, C. L., Mathew, R. C., Dean, J.-H. L., Yang, Y., Balfour, P. C., Shaw, P. W., Robinson, A. A., Salerno, M., Kramer, C. M., & Bourque, J. M. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.01.041 · Cited by 105
Colás, C., Brosa, M., Antón, E., Montoro, J., Navarro, A., Dordal, M. T., Dávila, I., Fernández‐Parra, B., Ibáñez, M. D. P., Lluch‐Bernal, M., et al. (2017) · Allergy · doi:10.1111/all.13099 · Cited by 101
“Previous studies have shown the high indirect costs generated by AR, which were evaluated in terms of work productivity and exceeded those of other chronic diseases such as asthma, diabetes, and coronary disease (11, 24).”
BackgroundResultInfluentialPollen calendars and maps of allergenic pollen in North America
Lo, F., Bitz, C. M., Battisti, D. S., & Hess, J. J. (2019) · Aerobiologia · doi:10.1007/s10453-019-09601-2 · Cited by 91
“…burden in the USA, with direct cost of treatment and medications estimated at $11.2 billion in 2005 (Meltzer and Bukstein 2011), and substantial indirect costs from lower workplace productivity, adverse school performance, and reduced quality of life (Lamb et al. 2006; Marcotte 2015; Nathan 2007).”
BackgroundInfluentialCost of anxiety disorders in Japan in 2008: a prevalence-based approach
Sado, M., Takechi, S., Inagaki, A., Fujisawa, D., Koreki, A., Mimura, M., & Yoshimura, K. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-338 · Cited by 92
“As a result, only one article [20] met the above-mentioned criteria for inclusion in the search results.”
BackgroundBachert, C., Vestenbæk, U., Christensen, J., Griffiths, U. K., & Poulsen, P. B. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02706.x · Cited by 95
Work productivity in rhinitis using cell phones: The MASK pilot study
Bousquet, J. J., Bewick, M., Arnavielhe, S., Mathieu‐Dupas, E., Murray, R., Bedbrook, A., Caimmi, D. P., Vandenplas, O., Hellings, P. W., Bachert, C., et al. (2017) · Allergy · doi:10.1111/all.13177 · Cited by 95
“The results of this pilot study confirm previous studies indicating that AR impacts work productivity.(2-12) However, this is the first study using an app to allow a daily evaluation.”
BackgroundResultAllergy immunotherapy: Reduced health care costs in adults and children with allergic rhinitis
Hankin, C. S., Cox, L., Bronstone, A. B., & Wang, Z. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.662 · Cited by 94
Efstathiou, C., Isukapalli, S., & Georgopoulos, P. G. (2010) · Atmospheric Environment · doi:10.1016/j.atmosenv.2010.12.008 · Cited by 89
“Introduction Allergic airway diseases (AAD), such as allergic rhino conjunctivitis and asthma, are a major cause of increased demands on health care resources, and of productivity loss (Schoenwetter et al., 2004; Lamb et al., 2006).”
BackgroundPalmares, J., Delgado, L., Cidade, M., Quadrado, M. J., & Filipe, H. P. (2010) · European Journal of Ophthalmology · doi:10.1177/112067211002000201 · Cited by 99
Hot topics in allergen immunotherapy, 2023: Current status and future perspective
Zemelka‐Wiącek, M., Agache, I. O., Akdiş, C. A., Akdiş, M., Casale, T. B., Dramburg, S., Jahnz‐Różyk, K., Kosowska, A., Matricardi, P. M., Pfaar, O., et al. (2023) · Allergy · doi:10.1111/all.15945 · Cited by 93
“161,162 166 These analyses allow for the comparison of different therapy methods and single products, facilitate the evaluation of the advantages and disadvantages from an economic point of view, as well as play an important role in decision-making, for example, to support reimbursement decisions.”
BackgroundClimate change effect on Betula (birch) and Quercus (oak) pollen seasons in the United States
Zhang, Y., Bielory, L., & Georgopoulos, P. G. (2013) · International Journal of Biometeorology · doi:10.1007/s00484-013-0674-7 · Cited by 85
Genomics of Compositae weeds: EST libraries, microarrays, and evidence of introgression
Lai, Z., Kane, N. C., Kozik, A., Hodgins, K. A., Dlugosch, K. M., Barker, M. S., Matvienko, M., Yu, Q., Turner, K. G., Pearl, S. A., et al. (2011) · American Journal of Botany · doi:10.3732/ajb.1100313 · Cited by 82
Zhang, W., Bansback, N. J., Boonen, A. E. R. C. H., Severens, J. L., & Anis, A. H. (2011) · Value in Health · doi:10.1016/j.jval.2011.07.009 · Cited by 82
“[6] Lamb CE, Ratner PH, Johnson CE, et al.”
BackgroundA circadian based inflammatory response – implications for respiratory disease and treatment
Comas, M., Gordon, C. J., Oliver, B. G. G., Stow, N. W., King, G. G., Sharma, P. K., Ammit, A. J., Grunstein, R. R., & Phillips, C. L. (2017) · Sleep Science and Practice · doi:10.1186/s41606-017-0019-2 · Cited by 84
Bleyl, J. W., Bareit, M., Casas, M. A., Chatterjee, S., Coolen, J., Hulshoff, A., Lohse, R., Mitchell, S., Robertson, M. W., & Ürge-Vorsatz, D. (2018) · Energy Efficiency · doi:10.1007/s12053-018-9707-8 · Cited by 80
Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis
Passalacqua, G., Baiardini, I., Senna, G., & Canonica, G. W. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04052.x · Cited by 81
Kulthanan, K., Chusakul, S., Recto, M. T., Gabriel, M. T. G., Aw, D. C., Prepageran, N., Wong, A., Leong, J., Foong, H. B. B., Quang, V. T., et al. (2018) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2018.10.4.370 · Cited by 78
“6 days per year.(31) As conservative estimate for the current analysis in Asia, the absenteeism rate of 3 days per year reported in Europe(1) was divided by half (1.”
BackgroundProductivity losses associated with cardiovascular disease: a systematic review
Gordois, A., Toth, P. P., Quek, R. G. W., Proudfoot, E. M., Paoli, C. J., & Gandra, S. R. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2016.1259571 · Cited by 76
“Presenteeism costs were reported in six US studies [18, 14, 13, 9, 12, 10] (in addition to absenteeism) but in no studies from”
BackgroundTang, K. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0209-z · Cited by 76
Rafferty, E., Yaghoubi, M., Taylor, J., & Farag, M. (2017) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-017-0066-7 · Cited by 75
Nasser, S. M., Vestenbæk, U., Beriot‐Mathiot, A., & Poulsen, P. B. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01743.x · Cited by 71
“Data on reduced productivity at work were estimated from published literature (13).”
MethodAnteceding factors predicting absenteeism and presenteeism in urban area in Malaysia
Wee, L. H., Yeap, L. L. L., Chan, C. M. H., Wong, J. E., Jamil, N. A., Nantha, Y. S., & Siau, C. S. (2019) · BMC Public Health · doi:10.1186/s12889-019-6860-8 · Cited by 74
Murota, H., Kitaba, S., Tani, M., Wataya‐Kaneda, M., Azukizawa, H., Tanemura, A., Umegaki, N., Terao, M., Kotobuki, Y., & Katayama, I. (2010) · Allergology International · doi:10.2332/allergolint.10-oa-0182 · Cited by 67
Persistent asthma, comorbid conditions and the risk of work disability: a prospective cohort study
Hakola, R., Kauppi, P., Leino, T., Ojajärvi, A., Pentti, J., Oksanen, T., Haahtela, T., Mika Kivimaki, B., & Vahtera, J. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02729.x · Cited by 62
“In line with previous studies, these results show that asthma is an important cause of occupational disability and related economical costs (4, 5, 8, 9, 20).”
BackgroundResultWitt, C. M., Reinhold, T., Jena, S., Brinkhaus, B., & Willich, S. N. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn370 · Cited by 61
Systematic review of pathways for the delivery of allergy services
Diwakar, L., Cummins, C., Lilford, R. J., & Roberts, T. E. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-012647 · Cited by 63
“Productivity losses associated with allergic rhinitis in the USA were higher than those due to stress, migraine and depression.(28) Studies have shown that effective allergy services can not only improve quality of life, but can also be cost-saving.”
BackgroundRyan, D. P., van Wijk, R. G., Angier, E., Kristiansen, M., Zaman, H., Sheikh, A., Cardona, V., Vidal, C., Warner, A., Agache, I. O., et al. (2017) · Allergy · doi:10.1111/all.13264 · Cited by 71
“These result in a significant impact at the personal level because of impaired quality of life, a significant impact on family and friends, on the healthcare system because of increased medical costs and at a societal level because of lost productivity through presenteeism and absenteeism.(6,7) Currently, allergy is o…”
BackgroundEfficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study
Bousquet, J., Bachert, C., Canonica, G. W., Mullol, J., Van Cauwenberge, P., Bindslev Jensen, C., Fokkens, W. J., Ring, J., Keith, P., Lorber, R., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02115.x · Cited by 62
“3 h/workday when symptoms were present (37).”
Inhalation of Toluene Diisocyanate Vapor Induces Allergic Rhinitis in Mice
Johnson, V. J., Yücesoy, B., Reynolds, J. S., Fluharty, K. L., Wang, W., Richardson, D. L., & Luster, M. I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1864 · Cited by 59
“Cost estimates indicate $593/year in productivity losses per employee with rhinitis vs $85/year for employees with asthma (5).”
BackgroundThe Burden of Asthma and Allergic Rhinitis
Patel, K. B., Mims, J. “., & Clinger, J. D. (2023) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2023.09.007 · Cited by 65
Cohen, B. (2023) · Pediatrics in Review · doi:10.1542/pir.2022-005618 · Cited by 56
Roger, A., Campillo, E. A., Torres, M. C., Millan, C., Jauregui, I., Mohedano, E., Liñán, S., Verdu, P., Rubira, N., Santaolalla, M., et al. (2016) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-016-0146-9 · Cited by 54
“Indirect costs of work and school absenteeism due to AR have been estimated to be higher than those caused by diabetes, migraine, anxiety, or asthma [11].”
BackgroundBelhassen, M., Demoly, P. M., Bloch-Morot, E., de Pouvourville, G., Ginoux, M., Chartier, A., Laforest, L., Serup‐Hansen, N., Toussi, M., & Ganse, E. H. V. (2016) · Allergy · doi:10.1111/all.13098 · Cited by 51
Zhang, Y., Isukapalli, S., Bielory, L., & Georgopoulos, P. G. (2012) · Atmospheric Environment · doi:10.1016/j.atmosenv.2012.11.028 · Cited by 48
“, 2010a), and the corresponding increased healthcare and financial costs have been reported in many industrialized countries (Lamb et al., 2006).”
BackgroundMeltzer, E. O., Ratner, P. H., & McGraw, T. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.05.007 · Cited by 48
Self-citationCanonica, G. W., Triggiani, M., & Senna, G. (2015) · Clinical and Molecular Allergy · doi:10.1186/s12948-015-0029-5 · Cited by 50
“…burden of AR is often ignored, but it is associated with a significant negative impact on productivity (comparable with that of heart disease and diabetes) [1] and high costs; estimated in Italy at € 210.43/patient/year, a total cost to the Italian economy of approximately € 2.4 billion/year [2–4].”
InfluentialMoyad, M. A., Robinson, L. E., Kittelsrud, J. M., Reeves, S. G., Weaver, S. E., Guzman, A. I., & Bubak, M. E. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0057-y · Cited by 45
Maspero, J. F., Lee, B. W., Katelaris, C. H., Potter, P. C., Cingi, C., As, L., Saffer, M., Nadeau, G. A., & Walters, R. D. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04025.x · Cited by 56
Stewart, M. G. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02937.x · Cited by 51
Nassef, M., Shapiro, G., Casale, T. B., & on behalf of the Respiratory & Allergic Disease Foundation (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x158057 · Cited by 46
“© 2006 librApHArM ltd – Curr Med res Opin 2006; 22(12) Identifying rhinitis and its subtypes Nassef et al.”
BackgroundInfluentialBousquet, J. J., Onorato, G. L., Bachert, C., Barbolini, M., Bedbrook, A., Bjermer, L. H., de Sousa, J. C., Chavannes, N. H., Cruz, Á. A., Keenoy, E. D. M., et al. (2017) · Clinical and Translational Allergy · doi:10.1186/s13601-017-0173-8 · Cited by 45
The increase in allergy and extended challenges
Linneberg, A. R. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02619.x · Cited by 44
Pharmacotherapy of allergic rhinitis: a pharmaco‐economic approach
Simoens, S., & Laekeman, G. (2009) · Allergy · doi:10.1111/j.1398-9995.2008.01909.x · Cited by 42
“A comparative analysis found that the indirect costs per employee per year amounted to US$593 for AR, $518 for high stress, $277 for migraine, $273 for depression, $269 for arthritis/rheumatism, $248 for anxiety disorder, $181 for respiratory infections, $105 for hypertension or high blood pressure, $95 for diabetes,…”
BackgroundRhinitis and its impact on work
Vandenplas, O., D’Alpaos, V., & Brussel, P. V. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f63d92 · Cited by 45
Intranasal Spray Medications for Maintenance Therapy of Allergic Rhinitis
Berger, W. E., & Meltzer, E. O. (2015) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2015.29.4215 · Cited by 40
Gardner, B. T., Dale, A. M., Buckner‐Petty, S., Dillen, L. V., Amick, B. C., & Evanoff, B. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000587 · Cited by 41
“23 All self-reported measures tested in our study overestimated the actual productivity loss measured in our cohort.”
Development of a Random Forest model for forecasting allergenic pollen in North America
Lo, F., Bitz, C. M., & Hess, J. J. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145590 · Cited by 43
Cost‐effectiveness of grass pollen allergen immunotherapy in adults
Bona, D. D., Bilancia, M., Albanesi, M., Caiaffa, M. F., & Macchia, L. (2020) · Allergy · doi:10.1111/all.14246 · Cited by 39
Hellings, P. W., Pugin, B., Mariën, G., Bachert, C., Breynaert, C. M., Bullens, D. M. A., Ceuppens, J. L., Clement, G., Cox, T., Ebo, D. G., et al. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0243-1 · Cited by 37
A Literature Review of Productivity Loss Associated with Hypertension in the United States
MacLeod, K. E., Ye, Z., Donald, B., & Wang, G. (2022) · Population Health Management · doi:10.1089/pop.2021.0201 · Cited by 40
“32 The third article estimated that the annual additional cost per person with hypertension was $291, controlling for patient characteristics, hypertension comorbidities, health behaviors and risk, and other chronic conditions.”
Measuring the productivity impacts of energy-efficiency: The case of high-efficiency buildings
Chatterjee, S., & Ürge-Vorsatz, D. (2021) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2021.128535 · Cited by 36
Devillier, P., Wahn, U., Zielen, S., & Heinrich, J. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1398082 · Cited by 37
Allergy immunotherapy in reducing healthcare cost
Cox, L. (2015) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000150 · Cited by 35
“annual cost of lost productivity attributable to allergic rhinitis was about $600 per employee (2002 value) [21].”
BackgroundLeitlinie zur (allergen-)spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen
Pfaar, O., Bachert, C., Bufe, A., Buhl, R., Ebner, C., Eng, P. A., Friedrichs, F., Fuchs, T., Hamelmann, E. H., Hartwig-Bade, D., et al. (2014) · Allergo Journal · doi:10.1007/s15007-014-0707-5 · Cited by 45
Petersen, K. D., Kronborg, C., Larsen, J. N., Dahl, R., & Gyrd‐Hansen, D. (2013) · World Allergy Organization Journal · doi:10.1186/1939-4551-6-15 · Cited by 37
“Other studies have shown presenteeism to constitute the greater part of productivity loss for the society [10].”
BackgroundAllergic and Nonallergic Rhinitis
Corren, J., Baroody, F. M., & Pawankar, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00043-7 · Cited by 39
Allergy, living and learning: diagnosis and treatment of allergic respiratory diseases in Europe.
Chivato, T., Valovirta, E. J., Dahl, R., de Monchy, J., Thomsen, A. B., Palkonen, S., & Jacobsen, L. (2012) · PubMed · Cited by 43
Local Respiratory Allergy: From Rhinitis Phenotype to Disease Spectrum
Testera‐Montes, A., Salas, M. L., Palomares, F., Ariza, A., Torres, M. J., Rondón, C., & Eguíluz‐Gracia, I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691964 · Cited by 34
“Allergic rhinitis (AR) and allergic asthma (AA) are very common diseases (1, 2) and account for high direct and indirect costs (3).”
BackgroundAtmospheric transport reveals grass pollen dispersion distances
Frisk, C. A., Apangu, G., Petch, G., Adams‐Groom, B., & Skjøth, C. A. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.152806 · Cited by 33
Presenteeism and productivity loss among nurses
Shdaifat, E. A. (2022) · International Journal of Occupational Safety and Ergonomics · doi:10.1080/10803548.2022.2108660 · Cited by 35
“[57] in the USA (USD 16,939,760 for all employees), although this was focused on the relatively minor health issue of allergic rhinitis.”
BackgroundAzelastine and olopatadine in the treatment of allergic rhinitis
Kaliner, M. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60355-9 · Cited by 32
More Sneezing, Less Crime? Seasonal Allergies, Transitory Costs and the Market for Offenses
Chalfin, A. J., Danagoulian, S., & Deza, M. (2018) · Journal of Health Economics · doi:10.1016/j.jhealeco.2019.102230 · Cited by 35
The Problem of Absenteeism and Presenteeism in the Workplace
Howard, K. J., Howard, J. T., & Smyth, A. F. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4839-6_8 · Cited by 45
Metadata
- Authors
- Lamb, C. E., Ratner, P. H., Johnson, C. E., Ambegaonkar, A. J., Joshi, A. V., Day, D., Sampson, N., & Eng, B.
- Affiliations
- PCA Occupational Medicine, Salem, VA, USA
- Sylvana Research (US)
- ExxonMobil (United States) (US)
- Pfizer (United States) (US)
- Novo Nordisk Inc., Princeton, NJ, USA
- Corresponding author
- Joshi, Ashish V.
- ORCID
- Joshi, Ashish V.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa Healthcare
- Published
- 2006-05-19
- Volume
- 22
- Issue
- 6
- Pages
- 1203-1210
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2098204210
- Cited by
- 288
- References
- 29
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 14 · 2023: 19 · 2022: 14 · 2021: 15 · 2020: 13 · 2019: 15 · 2018: 14 · 2017: 22 · 2016: 21 · 2015: 20 · 2014: 15 · 2013: 10 · 2012: 17
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medical Research and Opinion (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- West Virginia University
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Workplace Health and Well-being
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- allergic rhinitis, workplace productivity loss, absenteeism, presenteeism, employer costs, caregiving costs, employee health benefits, migraine, depression, asthma, respiratory infections
- MeSH terms
- Costs and Cost Analysis, Humans, Respiratory Hypersensitivity, Rhinitis, United States, Prevalence, Occupational Health, Workplace
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.